For the readers interested in the stock health of ImmunoGen Inc. (IMGN). It is currently valued at $6.47. When the transactions were called off in the previous session, Stock hit the highs of $7.26, after setting-off with the price of $7.20. Company’s stock value dipped to $6.82 during the trading on the day. When the trading was stopped its value was $6.83.Recently in News on January 3, 2022, ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on December 31, 2021 the compensation committee of the Company’s Board of Directors granted a non-qualified stock option award to purchase 16,800 shares of its common stock to a new employee under the ImmunoGen, Inc. Inducement Equity Incentive Plan (the “Inducement Plan”). The stock options were granted as an inducement material to the new employee’s becoming an employee of ImmunoGen in accordance with Nasdaq Listing Rule 5635(c)(4). You can read further details here
ImmunoGen Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.63 on 01/03/22, with the lowest value was $6.49 for the same time period, recorded on 01/13/22.
ImmunoGen Inc. (IMGN) full year performance was -6.57%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ImmunoGen Inc. shares are logging -40.53% during the 52-week period from high price, and 36.93% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.72 and $10.88.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 935022 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ImmunoGen Inc. (IMGN) recorded performance in the market was -7.95%, having the revenues showcasing 16.75% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.52B, as it employees total of 79 workers.
Specialists analysis on ImmunoGen Inc. (IMGN)
During the last month, 6 analysts gave the ImmunoGen Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.19, with a change in the price was noted +0.87. In a similar fashion, ImmunoGen Inc. posted a movement of +15.48% for the period of last 100 days, recording 3,021,721 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for IMGN is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: ImmunoGen Inc. (IMGN)
Raw Stochastic average of ImmunoGen Inc. in the period of last 50 days is set at 57.96%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 4.51%. In the last 20 days, the company’s Stochastic %K was 38.01% and its Stochastic %D was recorded 50.64%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -7.95%. Additionally, trading for the stock in the period of the last six months notably improved by 17.35%, alongside a downfall of -6.57% for the period of the last 12 months. The shares increased approximately by 0.44% in the 7-day charts and went down by 2.71% in the period of the last 30 days. Common stock shares were driven by 16.75% during last recorded quarter.